MISSION Therapeutics
About:
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.
Website: http://www.missiontherapeutics.com
Twitter/X: MISSIONTherapeu
Top Investors: Innovate UK, IP Group, SR One, Sofinnova Partners, Michael J. Fox Foundation
Description:
MISSION Therapeutics is a biotechnology company specializing in developing drugs that target the cellular process of deubiquitylation for the treatment of cancer and other diseases. Their focus is on developing small molecule drugs that selectively inhibit specific deubiquitylating enzymes (DUBs), which play crucial roles in regulating protein degradation and cellular processes. These drugs aim to intervene in disease mechanisms where DUB dysregulation is implicated, offering potential therapeutic benefits.
$180M
$10M to $50M
Cambridge, Cambridgeshire, United Kingdom
2011-01-01
info(AT)missiontherapeutics.com
Niall Martin, Steve Jackson, Xavier Jacq
51-100
2024-07-02
Private
© 2025 bioDAO.ai